BDSI Stock Price, Chart, Stats & News
BioDelivery Sciences International, Inc. (BDSI) does not currently pay a dividend.
BDSI chart
Fundamentals
Gross margin | 85.98% |
Operating margin | 22.27% |
Pretax margin | 17.77% |
Net margin | 50.90% |
Effective tax rate | -186.48% |
ROA | 26.14% |
ROE | 57.33% |
D/E | 0.31x |
Interest coverage ratio | 4.95x |
BDSI valuation
P/E | 6.82x |
P/S | 3.46x |
P/B | 3.07x |
P/CF | 14.07x |
P/FCF | 14.21x |
P/OCF | 14.07x |
PEG | 0.07x |
EV multiple | 14.20x |
About
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery system—a slender, dissolving polymer film intended for application to the inner cheek—in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain.
Similar securities
Based on sector and market capitalization
